Lisdexamfetamine

A prodrug of the d-isomer of amphetamine, a non-catecholamine sympathomimetic amine with central nervous system (CNS) stimulating activity. Upon… (More)
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (3)

NRP104Vyvanselisdexamfetamine dimesylate
lisdexamfetamine dimesylate 30 MG Oral Capsule [Vyvanse]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2015
Review
2015
Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta…
OBJECTIVES There is a lack of comparative effectiveness research among attention deficit hyperactivity disorder (ADHD) drugs in… (More)
Is this relevant?
2015
2015
Effects of lisdexamfetamine in a rat model of binge-eating.
Binge-eating disorder is a common psychiatric disorder affecting ~2% of adults. Binge-eating was initiated in freely-fed, lean… (More)
Is this relevant?
2015
2015
Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers.
CONTEXT Lisdexamfetamine is a pro-drug stimulant that requires the enzymatic hydrolysis of lysine from dexamphetamine for… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo-controlled trial.
This study evaluated the efficacy and tolerability of lisdexamfetamine (LDX) in the treatment of bipolar depression. Twenty-five… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
Pilot study of the effects of lisdexamfetamine on cocaine use: A randomized, double-blind, placebo-controlled trial.
BACKGROUND Amphetamine analogs have been demonstrated to have some efficacy in reducing use in cocaine dependent individuals… (More)
Is this relevant?
2015
2015
Effects of lisdexamfetamine and s-citalopram, alone and in combination, on effort-related choice behavior in the rat
Effort-related motivational symptoms, such as anergia, psychomotor retardation, and fatigue, are an important aspect of… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
New onset executive function difficulties at menopause: a possible role for lisdexamfetamine
Reports of cognitive decline, particularly in the domains of executive functions (EFs), are common among menopausal women. This… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
Treatment persistence in attention deficit/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications.
OBJECTIVE To compare treatment persistence in attention-deficit/hyperactivity disorder (ADHD) of patients initiated on… (More)
Is this relevant?
2013
2013
A cardiopulmonary study of lisdexamfetamine in adults with attention-deficit/hyperactivity disorder.
OBJECTIVES Due to concerns about the safety of stimulants for ADHD, novel assessments of the cardiopulmonary impact of these… (More)
Is this relevant?
2012
2012
Lisdexamfetamine and immediate release <ce:small-caps>d</ce:small-caps>-amfetamine – Differences in pharmacokinetic/pharmacodynamic relationships revealed by striatal microdialysis in freely-moving…
Lisdexamfetamine mesylate (Vyvanse(®)) is a novel prodrug approved for attention deficit hyperactivity disorder (ADHD). It is… (More)
Is this relevant?